Sickle Cell Gene Therapy Makers Would Pay For Fertility Services In Medicaid Payment Model
The manufacturer requirement, which invokes CMMI’s safe harbor authority, could help overcome some barriers to access that the companies are facing in Medicaid outside of the demonstration.
